Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Health-Care Overhaul and Drugmaker Outlook: Amgen
Health-Care Overhaul and Drugmaker Outlook: Amgen
Health-Care Overhaul and Drugmaker Outlook: Amgen
Submitted by
admin
on April 22, 2010 - 10:18am
Source:
WSJ Online
News Tags:
healthcare reform
Amgen
earnings
Eli Lilly
Gilead Sciences
JNJ
Abbott Laboratories
Headline:
Health-Care Overhaul and Drugmaker Outlook: Amgen
Do Not Allow Advertisers to Use My Personal information
